Fulcrum Therapeutics, Inc. FULC
3.69 USD -0.02 (-0.54%)
Regular-session close
3.68 -0.01 -0.27%
After hours · Nov 20, 4:07 PM ET
3.68 Day range 3.73
3.14 52-week range 14.60
- YTD
- -67.37%
- 1 year
- -66.64%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -84.77M | -21.90M | -110.66M | -112.56M | -81.05M | |
| -74.88M | -9.72M | -97.33M | -109.87M | -80.85M | |
| -1.18 | -0.16 | -1.59 | -2.44 | -2.29 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 197.53M | 59.41M | 26.66M | 36.19M | 36.50M | |
| 366.28M | 260.72M | 257.69M | 226.69M | 235.00M | |
| 17.28M | 17.68M | 22.50M | 27.74M | 23.46M | |
| 6.44M | 8.63M | 10.82M | 13.42M | 0 | |
| 349.00M | 243.03M | 235.19M | 198.94M | 211.54M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -60.06M | -2.22M | -90.97M | -97.05M | -78.48M | |
| 30.72M | 32.23M | -36.69M | 12.41M | -129.67M | |
| 168.67M | 2.75M | 118.12M | 84.32M | 186.51M | |
| -314.00K | -278.00K | -508.00K | -1.96M | -1.71M | |
| 139.32M | 32.76M | -9.54M | -314.00K | -21.64M |
